Samuel Chackalamannil Selected Research

Samuel Chackalamannil Research Topics

3	Thrombosis (Thrombus) 01/2009 - 01/2003
3	Hemorrhage 04/2006 - 01/2003
2	Parkinson Disease (Parkinson's Disease) 07/2008 - 07/2008
2	Unstable Angina 06/2008 - 01/2003
2	Erectile Dysfunction 05/2005 - 03/2004
2	Atherosclerosis 03/2003 - 01/2003
1	Body Weight (Weight, Body) 05/2018
1	Type 2 Diabetes Mellitus (MODY) 05/2018
1	Hepatitis C 12/2016
1	Infections 03/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2010
1	Acute Coronary Syndrome 06/2008
1	ST Elevation Myocardial Infarction 06/2008
1	Obesity 04/2008
1	Myocardial Infarction 01/2003
1	Vascular System Injuries 01/2003
1	Atherosclerotic Plaque (Atheroma) 01/2003
1	Stroke (Strokes) 01/2003

4	Thrombin FDA Link 04/2006 - 01/2003
3	Thrombin Receptors (Thrombin Receptor)IBA 01/2009 - 01/2003
2	grazoprevirIBA 12/2016 - 03/2014
2	vorapaxarIBA 01/2009 - 06/2008
2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 07/2008 - 07/2008
2	5- amino- 7- (2- phenylethyl)- 2- (2- furyl)pyrazolo(4,3- e)- 1,2,4- triazolo(1,5- c)pyrimidineIBA 07/2008 - 07/2008
2	FibrinIBA 04/2006 - 01/2003
2	Phosphodiesterase 5 InhibitorsIBA 05/2005 - 03/2004
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 05/2018
1	Glucose (Dextrose)FDA LinkGeneric 05/2018
1	elbasvirIBA 03/2014
1	Protease Inhibitors (Protease Inhibitor)IBA 03/2014
1	11-beta-Hydroxysteroid Dehydrogenase Type 1IBA 03/2010
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 06/2008
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 04/2008
1	AnticoagulantsIBA 04/2006
1	purineIBA 05/2005
1	IsoenzymesIBA 05/2005
1	GuanineIBA 03/2004
1	AntithrombinsIBA 01/2003
1	Serine Proteases (Serine Protease)IBA 01/2003
1	PAR-1 ReceptorIBA 01/2003

1	Therapeutics 03/2014
1	Secondary Prevention 06/2008